12/18
04:05 pm
npce
NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/17
12:39 pm
npce
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at JPMorgan Chase & Co. from $9.00 to $14.00. They now have an "overweight" rating on the stock.
Medium
Report
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at JPMorgan Chase & Co. from $9.00 to $14.00. They now have an "overweight" rating on the stock.
12/12
04:05 pm
npce
NeuroPace to Host Investor Day on January 28th in New York City
Low
Report
NeuroPace to Host Investor Day on January 28th in New York City
12/4
04:14 pm
npce
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting [Yahoo! Finance]
Low
Report
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting [Yahoo! Finance]
12/4
04:05 pm
npce
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
Low
Report
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting
12/3
04:15 pm
npce
NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome [Yahoo! Finance]
Medium
Report
NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome [Yahoo! Finance]
12/3
04:05 pm
npce
NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome
Medium
Report
NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome
11/18
01:40 pm
npce
What Makes NeuroPace (NPCE) a New Buy Stock [Yahoo! Finance]
Low
Report
What Makes NeuroPace (NPCE) a New Buy Stock [Yahoo! Finance]
11/18
11:38 am
npce
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade [Yahoo! Finance]
Medium
Report
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade [Yahoo! Finance]
11/14
05:54 am
npce
NeuroPace Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
NeuroPace Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/13
12:53 pm
npce
NeuroPace, Inc. (NASDAQ: NPCE) had its price target lowered by analysts at Wells Fargo & Company from $15.00 to $13.00. They now have an "overweight" rating on the stock.
Low
Report
NeuroPace, Inc. (NASDAQ: NPCE) had its price target lowered by analysts at Wells Fargo & Company from $15.00 to $13.00. They now have an "overweight" rating on the stock.
11/13
02:26 am
npce
NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]
High
Report
NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]
11/12
05:03 pm
npce
NeuroPace Inc.: Q3 Earnings Snapshot [Yahoo! Finance]
High
Report
NeuroPace Inc.: Q3 Earnings Snapshot [Yahoo! Finance]
11/12
04:05 pm
npce
NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
High
Report
NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
11/9
07:37 am
npce
private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week [Yahoo! Finance]
Medium
Report
private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week [Yahoo! Finance]
11/4
04:19 pm
npce
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy [Yahoo! Finance]
Medium
Report
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy [Yahoo! Finance]
11/4
04:05 pm
npce
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
Medium
Report
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
10/28
09:51 am
npce
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? [Yahoo! Finance]
Low
Report
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? [Yahoo! Finance]
10/22
04:05 pm
npce
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024
Low
Report
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024
10/16
04:05 pm
npce
NeuroPace Continues to Strengthen Management Team
Low
Report
NeuroPace Continues to Strengthen Management Team